Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 8, 1996, Pages 660-664

  Hong, C Y ^a,b   Huang, S S ^a   Tsai, S K ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Antioxidant; Arrhythmia; Magnolol; Myocardial ischaemia; Reperfusion

Indexed keywords

ALPHA TOCOPHEROL; MAGNOLOL; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; CORONARY ARTERY; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIGATION; LIPID PEROXIDATION; MALE; MITOCHONDRION; NONHUMAN; RAT;

EID: 0029828414     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01753.x     Document Type: Article

References (33)

1. Teng CM, Chen CC, Ko FN et al. Two antiplatelet agents from Magnolia officinalis. Thromb. Res. 1988; 50: 757-65.
2. Teng CM, Yu SM, Chen CC, Huang YL, Huang TF. EDRFrelease and Ca"-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Life Sci. 1990; 47: 1153-61.
3. Lo YC, Teng CM, Chen CF, Chen CC, Hong CY. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem. Pharmacol. 1994; 47: 549-53.
4. Lin M H, Chao HT, Hong CY. Magnolol protects human sperm motility against lipid peroxidation: Measured with a sperm head fixation method. Arch. Androl. 1995; 34: 151-6.
5. Walker MJA, Curtis MJ, Hearse DJ et al. The Lambeth conventions: Guidelines for the study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovasc. Res. 1988; 22: 447-55.
6. Johnston KM, MacLeod BA, Walker MJA. Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can. J. Physiol. Pharmacol. 1983; 61: 1340-53.
7. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc. Res. 1994; 28: 303-11.
8. Wolfe CL, Donnelly TJ, Sievers R, Parmley WW. Myocardial protection with verapamil during ischemia and reperfusion: Dissociation between myocardial salvage and the degree of ATP depletion during ischemia. Cardiovasc. Res. 1991; 25: 101-9.
9. Cruickshank JM. The adrenergic system and prevention of myocardial damage by beta-blockade: A clinical review. J. Cardiovasc. Pharmacol. 1989; 14: S20-3.
10. Lukovic L, Petty MA, Bolkenius FN, Gristor M, Dow J, Jong WD. Protection of infarcted chronically reperfused hearts by an alphatocopherol analogue. Eur. J. Pharmacol. 1993; 233: 63-70.
11. Gross GJ, Auchampach JA, Maruyama M, Warltier DC, Pieper GM. Cardioprotective effects of nicorandil. J. Cardiovasc. Pharmacol. 1992; 20: S22-8.
12. Hock CE, Ribeiro LTG, Lefer AM. Preservation of ischémie myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infartion. Am. Heart J. 1985; 109: 222-8.
13. Inculano M, Squadrito F, Altavilla D et al. Protective effect of L-659989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats. J. Cardiovasc. Pharmacol. 1994; 23: 7-12.
14. Kanayama T, Kimura Y, Mizogami S. A new prostacyclin analog, KP-10614, inhibits platelet polymorphonuclear leucocyte interaction and limits experimental infarct size in rat heart. J. Pharmacol. Exp. Ther. 1993; 266: 344-9.
15. Wainwright CL, Martorana PA. Pirsidomine, a novel nitric oxide donor, suppresses ischémie arrhythmia in anesthetized pigs. J. Cardiovasc. Pharmacol. 1993; 22: S44-50.
16. Watanabe K, Watanabe H, Goto Y, Yamaguchi M, Yamamoto N, Hagino K. Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: Central depressant effects. Planta Med. 1983; 49: 103-8.
17. Clark AM, Elferaly FS, Li WS. Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J. Pharm. Sci. 1981; 70: 951-2.
18. Wang JP, Hsu MF, Raung SL, Chen CC, Kuo JS, Teng CM. Anti-inflammatory and analgesic effects of magnolol. Arch. Pharmacol. 1992; 346: 707-12.
19. Wang JP, Raung SL, Chen CC, Kuo JS, Teng CM. The inhibitory effect of magnolol on cutaneous permeability in mice is probably mediated by a nonselective vascular hyporeactivity to mediators. Arch. Pharmacol. 1993; 348: 663-9.
20. Tsai TH, Chou CJ, Chen CF. Disposition of magnolol after intravenous bolus and infusion in rabbits. Drug Metab. Dispos. 1994; 22:518-21.
21. Tsai TH, Chou CI, Cheng FC, Chen CF. Pharmacokinctics and brain distribution of magnolol in the rat after intravenous bolus injection. J. Pharm. Pharmacol. 1996; 48: 57-9.
22. Hong CY, Lee MF, Lai LJ, Wang CP. Effect of lipid peroxidation on beating frequency of human sperm tail. Andrologia 1994; 26: 61-5.
23. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 1993; 328: 1450-6.
24. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 1993; 328: 1444-9.
25. Riemersma RA, Wood DA, Maclntyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991; 337: 1-5.
26. Kardinaal AFM, Kok FJ, Ringstad J et al. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC study. Lancet 1993; 342: 1379-84.
27. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout
28. D. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 1993; 342: 1007-11.
29. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-7.
30. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 1995; 332: 488-93.
31. Siveski-IIiskovic N, Hill M, Chow DA, Singal PK. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 1995; 91: 10-15.
32. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 1985; 312: 159-63.
33. Mullane KM, Westlin W, Kraemer R. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischaemia and reperfusion. Ann. N.Y. Acad.Sci. 1988; 524: 103-21.